These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2167797)

  • 21. Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3.
    Hallson PC; Rose GA; Sulaiman S
    Clin Sci (Lond); 1982 Apr; 62(4):421-5. PubMed ID: 7067361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperuricosuric calcium urolithiasis.
    Moe OW; Xu LHR
    J Nephrol; 2018 Apr; 31(2):189-196. PubMed ID: 29368300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of urate in patients with calcium oxalate stone disease.
    Tiselius HG; Larsson L
    Urol Res; 1983; 11(6):279-83. PubMed ID: 6686365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth retardation of weddellite (calcium oxalate dihydrate) by sodium copper chlorophyllin.
    Tawashi R; Cousineau M
    Invest Urol; 1980 Sep; 18(2):86-9. PubMed ID: 7437122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations between the metastable solutions of calculus-forming salts and crystals from coexistent insoluble urinary components].
    Leskovar P; Hartung R
    Z Urol Nephrol; 1978 Sep; 71(9):601-11. PubMed ID: 716644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S; Hayashi K; Eto K
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of glucose intake on urine saturation with calcium oxalate, calcium phosphate, uric acid and sodium urate.
    Głuszek J
    Int Urol Nephrol; 1988; 20(6):657-64. PubMed ID: 3229936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleation and aggregation of calcium oxalate in whole urine; spectrophotometric sedimentation analysis: a new approach to study the aggregation of calcium oxalate dihydrate.
    Baumann JM; Affolter B; Caprez U; Lauper D; Maier F; Siegrist HP; Zysset T
    Urol Res; 2000 Jun; 28(3):147-54. PubMed ID: 10929422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of heparan sulphate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine.
    Suzuki K; Ryall RL
    Br J Urol; 1996 Jul; 78(1):15-21. PubMed ID: 8795393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine?
    Grover PK; Ryall RL; Marshall VR
    Clin Chim Acta; 1990 Oct; 190(3):223-38. PubMed ID: 2253402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro.
    Ryall RL; Grover PK; Stapleton AM; Barrell DK; Tang Y; Moritz RL; Simpson RJ
    Clin Sci (Lond); 1995 Nov; 89(5):533-41. PubMed ID: 8549069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urate and calcium oxalate stones: from repute to rhetoric to reality.
    Grover PK; Ryall RL
    Miner Electrolyte Metab; 1994; 20(6):361-70. PubMed ID: 7783698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.